How Accurate Are Gut Microbiome Tests? What the Science Says

Commercial gut microbiome tests have exploded in popularity, with UK companies like Zoe, Atlas Biomed, and Thriva offering stool-based analysis for £100–£300. They promise personalised dietary recommendations based on your unique microbial profile. But how accurate are the results — and what can they actually tell you?

What Microbiome Tests Measure

Most commercial tests use one of two sequencing approaches:

16S rRNA sequencing — This technique targets a specific gene found in all bacteria, using variable regions to identify organisms to the genus level. It is relatively inexpensive and widely used but has significant limitations: it cannot reliably identify bacteria to the species or strain level, it misses non-bacterial organisms (viruses, fungi), and it provides limited functional information about what the bacteria are actually doing.

Shotgun metagenomics — This more comprehensive approach sequences all DNA in a sample, providing species- and strain-level identification, functional gene analysis, and detection of non-bacterial organisms. It is more expensive but significantly more informative. Zoe and some premium tests use this method.

Both methods analyse DNA extracted from a stool sample, which represents the bacteria shed from the lower gut. They do not directly measure the microbiome of the small intestine, stomach, or mucosal layer — these require invasive sampling.

Reproducibility: The Core Problem

The most significant challenge facing commercial microbiome tests is reproducibility. Several studies have highlighted concerning inconsistencies:

Within-sample variation — A study by Costea et al. (2017, Nature Biotechnology) found that different DNA extraction protocols applied to the same stool sample could produce substantially different microbial profiles. The choice of extraction kit alone can shift the apparent abundance of major bacterial groups by 10–20%.

Between-lab variation — The International Human Microbiome Standards (IHMS) project compared results from multiple laboratories analysing identical samples. They found significant variation in the relative abundance of key bacterial taxa, even when labs used the same sequencing platform.

Temporal variation — Your microbiome fluctuates naturally from day to day based on what you eat, how you sleep, stress levels, and bowel transit time. A study by David et al. (2014, Nature) showed that diet changes could shift the microbiome composition within 24 hours. A single snapshot may not represent your typical microbial state.

A widely reported investigation by the American Gastroenterological Association (2019) sent identical stool samples to multiple commercial testing companies and received different results from each. While the broad compositional patterns were similar, the specific bacterial percentages and dietary recommendations varied considerably.

What Results Can Tell You

Despite these limitations, microbiome tests can provide some genuinely useful information:

Diversity metrics — Alpha diversity (the variety of species in your sample) is one of the more reproducible measurements. Low diversity is consistently associated with various health conditions, and tracking changes in diversity over time can be meaningful.

Major compositional patterns — The presence or absence of major bacterial groups (Bacteroidetes, Firmicutes, Proteobacteria) is relatively reliably detected, though the precise ratios should be interpreted cautiously.

Specific pathogens — Some tests can identify potentially problematic organisms such as Clostridioides difficile or high levels of Proteobacteria, which may warrant clinical follow-up.

Broad dietary guidance — If your test shows low Bifidobacterium levels and low diversity, the advice to eat more fibre and fermented foods is sound — though this is advice that benefits almost everyone regardless of test results.

What Results Cannot Tell You

Causation — A test showing low levels of a "beneficial" bacterium does not mean that deficiency is causing your symptoms. Correlation and causation are routinely conflated in commercial test reports.

Clinical diagnosis — No commercial microbiome test can diagnose a disease. Conditions like SIBO, inflammatory bowel disease, and coeliac disease require separate, validated clinical tests.

Precise supplement recommendations — The idea that a test can tell you exactly which probiotic strain to take is currently beyond the science. We do not yet have enough research to make reliable personalised probiotic prescriptions based on stool analysis.

Functional activity — Most tests measure which bacteria are present, not what they are doing. The same species can behave differently depending on the broader microbial community and the host's diet.

Expert Opinions

Professor Tim Spector (co-founder of Zoe and professor at King's College London) has argued that microbiome testing, when combined with other biomarkers such as blood sugar and blood fat responses, can provide meaningful personalised nutrition guidance. The PREDICT studies published in Nature Medicine support this position for dietary response prediction.

However, the British Society of Gastroenterology has noted that "the clinical utility of commercial microbiome testing remains unproven" and that results should not be used to make medical decisions without professional guidance.

Professor Jack Gilbert (University of California San Diego), a leading microbiome researcher, has cautioned that "most commercial microbiome tests are not clinically validated and the recommendations they provide are not evidence-based in the traditional medical sense."

Key Takeaways

• Microbiome tests can provide a broad overview of your gut microbial community, but the precision of results varies significantly between tests, labs, and even samples taken on different days
• Shotgun metagenomics provides more detailed information than 16S rRNA sequencing, but both have limitations
• Diversity metrics and major compositional patterns are the most reliable outputs
• Specific dietary recommendations based on microbiome tests should be treated as suggestions, not prescriptions
• No commercial test can diagnose disease or replace clinical investigation
• If you have concerning digestive symptoms, see your GP before investing in a commercial test
• The field is improving rapidly, and test accuracy and clinical utility are likely to increase significantly over the coming years. For a comparison of specific UK tests, see our practical testing guide, and for a detailed look at the most popular option, see our Zoe review